Szatmári István

1.

Jambrovics, K., Al-Hadban, W., Türk-Mázló, A., Szatmári, I., Dobó, B., Reményi, G., Jóna, Á., Koncz, G., Balajthy, Z.: Anti-inflammatory 25(OH)D3, a natural steroid hormone, may complement all-trans retinoic acid therapy for differentiation syndrome in acute promyelocytic leukemia.
Cell Death Dis. 16 (1), 1-10, (article identifier: 787), 2025.

doi DEA

Journal metrics:

Q1 Cancer Research (2024)

Q1 Cell Biology (2024)

D1 Cellular and Molecular Neuroscience (2024)

Q1 Immunology (2024)

D1 Medicine (miscellaneous) (2024)

2.

Balla, V., Németh, E., Szatmári, I., Péli-Szabó, J., Képes, Z., Trencsényi, G., Kertész, I., Forgács, V., Jószai, I.: Az SzR72 kinurénsav-analóg 11C izotóppal történő jelzése és preklinikai vizsgálata.
In: Őszi Radiokémiai Napok 2024 : A konferencia programja és előadás kivonatai, Magyar Kémikusok Egyesülete, Budapest, 33-38, 2024. ISBN: 9786156018267

DEA

3.

Póliska, S., Fareh, C., Lengyel, A., Göczi, L., Tőzsér, J., Szatmári, I.: Comparative transcriptomic analysis of Illumina and MGI next-generation sequencing platforms using RUNX3- and ZBTB46-instructed embryonic stem cells.
Front. Genet. 14, 1-14, (article identifier: 1275383), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Genetics

Q2 Genetics (clinical)

Q2 Molecular Medicine

4.

Kolostyák, Z., Bojcsuk, D., Baksa, V., Máthéné Szigeti, Z., Bene, K., Czimmerer, Z., Botó, P., Fadel, L., Póliska, S., Halász, L., Tzerpos, P., Berger, W. K., Villabona-Rueda, A., Varga, Z., Kovács, T., Patsalos, A., Pap, A., Vámosi, G., Bai, P., Dezső, B., Spite, M., D'Alessio,, F. R., Szatmári, I., Nagy, L.: EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages.
JCI Insight. 9 (17), 1-21, (article identifier: 164009), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Medicine (miscellaneous)

5.

Jambrovics, K., Botó, P., Pap, A., Sarang, Z., Kolostyák, Z., Czimmerer, Z., Szatmári, I., Fésüs, L., Uray, I. P., Balajthy, Z.: Transglutaminase 2 associated with PI3K and PTEN in a membrane-bound signalosome platform blunts cell death.
Cell Death Dis. 14 (3), 1-10, (article identifier: 217), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Cancer Research

Q1 Cell Biology

Q1 Cellular and Molecular Neuroscience

Q1 Immunology

D1 Medicine (miscellaneous)

6.

Laczik, M., Erdős, E., Ozgyin, L., Hevessy, Z., Csősz, É., Kalló, G., Nagy, T., Barta, E., Póliska, S., Szatmári, I., Bálint, B. L.: Extensive proteome and functional genomic profiling of variability between genetically identical human B-lymphoblastoid cells.
Sci Data. 9 (1), 1-12, (article identifier: 763), 2022.

doi DEA WoS Scopus

Journal metrics:

D1 Computer Science Applications

D1 Education

D1 Information Systems

D1 Library and Information Sciences

D1 Statistics and Probability

D1 Statistics, Probability and Uncertainty

7.

Czimmerer, Z., Halász, L., Dániel, B., Varga, Z., Bene, K., Domokos, A., Hoeksema, M., Shen, Z., Berger, W. K., Silye-Cseh, T., Jambrovics, K., Kolostyák, Z., Fenyvesi, F., Váradi, J., Póliska, S., Hajas, G., Szatmári, I., Glass, C. K., Bácsi, A., Nagy, L.: The epigenetic state of IL-4-polarized macrophages enables inflammatory cistromic expansion and extended synergistic response to TLR ligands.
Immunity. 55 (11), 2006-2026, 2022.

doi DEA WoS Scopus

Journal metrics:

D1 Immunology

D1 Immunology and Allergy

D1 Infectious Diseases

8.

Botó, P., Gerzsenyi, T. B., Lengyel, A., Szúnyog, B., Szatmári, I.: Zbtb46-dependent altered developmental program in embryonic stem cell-derived blood cell progenitors.
Stem Cells. 39 (10), 1322-1334, 2021.

doi DEA

Journal metrics:

Q2 Cell Biology

Q1 Developmental Biology

Q1 Medicine (miscellaneous)

Q1 Molecular Medicine

9.

Dániel, B., Czimmerer, Z., Halász, L., Botó, P., Kolostyák, Z., Póliska, S., Berger, W. K., Tzerpos, P., Nagy, G., Horváth, A., Hajas, G., Silye-Cseh, T., Nagy, A., Sauer, S., Francois-Deleuze, J., Szatmári, I., Bácsi, A., Nagy, L.: The transcription factor EGR2 is the molecular linchpin connecting STAT6 activation to the late, stable epigenomic program of alternative macrophage polarization.
Genes Dev. 34 (21-22), 1474-1492, 2020.

doi DEA WoS Scopus

Journal metrics:

D1 Developmental Biology

D1 Genetics

10.

Smith, D. G., Martinelli, R., Besra, G. S., Illarionov, P. A., Szatmári, I., Brázda, P., Allen, M. A., Xu, W., Wang, X., Nagy, L., Dowell, R. D., Rook, G. A. W., Rosa, B. L., Lowry, C. A.: Identification and characterization of a novel anti-inflammatory lipid isolated from Mycobacterium vaccae, a soil-derived bacterium with immunoregulatory and stress resilience properties.
Psychopharmacology. 236 (5), 1653-1670, 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmacology

11.

Agostini, M., Schoenmakers, E., Beig, J., Fairall, L., Szatmári, I., Rajanayagam, O., Muskett, F. W., Adams, C., Marais, A. D., O'Rahilly, S., Semple, R. K., Nagy, L., Majithia, A. R., Schwabe, J. W. R., Blom, D. J., Murphy, R., Chatterjee, K., Savage, D. B.: A Pharmacogenetic Approach to the Treatment of Patients With PPARG Mutations.
Diabetes. 67 (6), 1086-1092, 2018.

doi DEA WoS Scopus

Journal metrics:

D1 Endocrinology, Diabetes and Metabolism

D1 Internal Medicine

12.

Botó, P., Csuth, T. I., Szatmári, I.: RUNX3-Mediated Immune Cell Development and Maturation.
Crit. Rev. Immunol. 38 (1), 63-78, 2018.

doi DEA

Journal metrics:

Q3 Immunology

Q3 Immunology and Allergy

13.

Takács, E., Botó, P., Simó, E., Csuth, T. I., Tóth, B., Raveh-Amit, H., Pap, A., Kovács, E. G., Kobolák, J., Benkő, S., Dinnyés, A., Szatmári, I.: Immunogenic Dendritic Cell Generation from Pluripotent Stem Cells by Ectopic Expression of Runx3.
J. Immunol. 198 (1), 239-248, 2017.

doi DEA

Journal metrics:

Q1 Immunology

14.

Kiss, M., Czimmerer, Z., Nagy, G., Bieniasz-Krzywiec, P., Ehling, M., Pap, A., Póliska, S., Botó, P., Tzerpos, P., Horváth, A., Kolostyák, Z., Dániel, B., Szatmári, I., Mazzone, M., Nagy, L.: Retinoid X receptor suppresses a metastasis-promoting transcriptional program in myeloid cells via a ligand-insensitive mechanism.
Proc. Natl. Acad. Sci. U. S. A. 114 (40), 10725-10730, 2017.

doi DEA

Journal metrics:

D1 Multidisciplinary

15.

Bencsik, R., Botó, P., Szabó, R. N., Tóth, B., Simó, E., Bálint, B. L., Szatmári, I.: Improved transgene expression in doxycycline-inducible embryonic stem cells by repeated chemical selection or cell sorting.
Stem Cell Res. 17 (2), 228-234, 2016.

doi DEA

Journal metrics:

Q2 Cell Biology

Q1 Developmental Biology

D1 Medicine (miscellaneous)

16.

Rákosy, Z., Ecsedi, S., Tóth, R., Vízkeleti, L., Hernandez, V. H., Lázár, V., Emri, G., Szatmári, I., Herceg, Z., Ádány, R., Balázs, M.: Integrative genomics identifies gene signature associated with melanoma ulceration.
PLoS One. 8 (1), e54958, 2013.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

17.

Kis-Tóth, K., Bacskai, I., Gogolák, P., Türk-Mázló, A., Szatmári, I., Rajnavölgyi, É.: Monocyte-derived dendritic cell subpopulations use different types of matrix metalloproteinases inhibited by GM6001.
Immunobiology. 218 (11), 1361-1369, 2013.

doi DEA

Journal metrics:

Q1 Hematology

Q2 Immunology

Q1 Immunology and Allergy

18.

Gyöngyösi, A., Szatmári, I., Pap, A., Dezső, B., Pos, Z., Széles, L., Varga, T., Nagy, L.: RDH10, RALDH2, and CRABP2 are required components of PPARγ-directed ATRA synthesis and signaling in human dendritic cells.
J. Lipid Res. 54 (9), 2458-2474, 2013.

doi DEA

Journal metrics:

Q1 Biochemistry

Q1 Cell Biology

D1 Endocrinology

19.

Tsakiris, I., Töröcsik, D., Gyöngyösi, A., Dózsa, A., Szatmári, I., Szántó, A., Soós, G., Nemes, Z., Igali, L., Márton, I., Takáts, Z., Nagy, L., Dezső, B.: Carboxypeptidase-M is regulated by lipids and CSFs in macrophages and dendritic cells and expressed selectively in tissue granulomas and foam cells.
Lab. Invest. 92 (3), 345-361, 2012.

doi DEA WoS Scopus

Journal metrics:

Q2 Cell Biology

Q2 Molecular Biology

D1 Pathology and Forensic Medicine

20.

Nagy, L., Szántó, A., Szatmári, I., Széles, L.: Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response.
Physiol. Rev. 92 (2), 739-789, 2012.

doi DEA

Journal metrics:

D1 Medicine (miscellaneous)

D1 Molecular Biology

D1 Physiology

D1 Physiology (medical)

21.

Szatmári, I., Fésüs, L.: Pluripotens sejtek alkalmazása a jelen és a jövő orvostudományában.
Meditor. 1-2, 64-81, 2012.

DEA

22.

Póliska, S., Csánky, E., Szántó, A., Szatmári, I., Meskó, B., Széles, L., Dezső, B., Scholtz, B., Podani, J., Kilty, I., Takács, L., Nagy, L.: Chronic Obstructive Pulmonary Disease-Specific Gene Expression Signatures of Alveolar Macrophages as well as Peripheral Blood Monocytes Overlap and Correlate with Lung Function.
Respiration. 81 (6), 499-510, 2011.

doi DEA

Journal metrics:

Q1 Pulmonary and Respiratory Medicine

23.

Iacovino, M., Chong, D., Szatmári, I., Hartweck, L., Rux, D., Caprioli, A., Cleaver, O., Kyba, M.: HoxA3 is an apical regulator of haemogenic endothelium.
Nat. Cell Biol. 13 (1), 72-78, 2011.

doi DEA

Journal metrics:

D1 Cell Biology

24.

Aradi, J., Balajthy, Z., Csősz, É., Scholtz, B., Szatmári, I., Tőzsér, J., Varga, T.: Molecular therapies.
University of Debrecen, Debrecen, 120 p., 2011.

DEA

25.

Aradi, J., Balajthy, Z., Csősz, É., Scholtz, B., Szatmári, I., Tőzsér, J., Varga, T.: Molekuláris terápiák.
Debreceni Egyetem, Debrecen, 112 p., 2011.

DEA